Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BOSTON SCIENTIFIC CORP

Get SEC filing alerts via email and in your feed for BOSTON SCIENTIFIC CORP

BSX

BOSTON SCIENTIFIC CORP

About BOSTON SCIENTIFIC CORP

Boston Scientific Corporation develops, manufactures, and markets medical devices across interventional medical specialties, focusing on less-invasive treatments. Its core segments include MedSurg (endoscopy, urology, neuromodulation) and Cardiovascular (cardiology, cardiac rhythm management, electrophysiology, peripheral interventions). Serving hospitals and healthcare providers globally, Boston Scientific offers innovative technologies that improve patient outcomes, reduce healthcare costs, and enhance procedural efficiency through a broad portfolio of proprietary devices and solutions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BOSTON SCIENTIFIC CORP

1
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 11.6% Revenue Growth to $5.203 Billion in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 19.9% Revenue Growth to $20.074 Billion in 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 20.3% Revenue Growth to $5.065 Billion in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 22.8% Revenue Growth to $5.061 Billion in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 20.9% Revenue Growth to $4.663 Billion in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 17.6% Revenue Growth to $16.747 Billion for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
BOSTON SCIENTIFIC CORP Boston Scientific Reports 19.4% Revenue Growth in Q3 2024, Driven by Strong Cardiology Performance

Via official filing (AI summary) | over 1 year ago | 0 comments